Therapies coverage from Pharma Journal: advanced therapies, biologics, cell and gene treatments and the next generation of medicine, with the science, trials and approvals behind them.
NICE NG28 now recommends SGLT2 inhibitors as first-line therapy alongside metformin for most adults with type 2 diabetes, prioritising cardiorenal protection from diagnosis.
By Dr. Eleanor Vance, Regulatory Affairs Editor
Huntington's disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base po
By Dr. Eleanor Vance, Regulatory Affairs Editor
Testosterone replacement therapy is widely requested, yet appropriate use depends on accurate diagnosis. True androgen deficiency is a clinical and biochemical syndrome. Symptoms must align with repea
By Tom Okafor, Clinical Trials Correspondent
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy